Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Cancer Medicine|May 19, 2020
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemiaXuelian Hu, Haodong Cai, Lu Zheng, et al.Blood|May 28, 2015
Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent mannerWeiwei Yi, Xuelian Hu, Zhiyang Chen, et al.Molecular Therapy Oncolytics|July 31, 2020
Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic LeukemiaXiangyu Zhao, Junfang Yang, Xian Zhang, et al.Nature Communications|September 2, 2014
TSC1 controls macrophage polarization to prevent inflammatory diseaseLinnan Zhu, Tao Yang, Longjie Li, et al.British Journal of Haematology|July 1, 2026
Hyperlactataemia in lymphoma-associated haemophagocytic lymphohistiocytosis: Linked to monocytic glycolysis and adverse prognosisXuelian Hu, Liangshun You, Jinghan Wang, et al.Blood|March 16, 2025
Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in ChinaDe Zhou, Xianbo Huang, Lixia Zhu, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 31, 2022
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphomaZhitao Ying, Ting He, Shanzhao Jin, et al.Molecular Psychiatry|September 21, 2022
Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal modelGuangdan Yu, Yixun Su, Chen Guo, et al.JCI Insight|May 22, 2025
Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cellsJiali Cheng, Xuelian Hu, Zhenyu Dai, et al.BMC Cancer|February 26, 2021
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignanciesZhitao Ying, Ting He, Xiaopei Wang, et al.Pageof 7